Replies to post #12883 on The Rising Influence of Rising Affluence

[jbog]

ABT’s 2Q16 sales in emerging markets—excluding Venezuela—

That's a good one, emerging markets are emerging markets. Period.

I wonder how they did in the BRIC nations without the nations that start with B or R?

[DewDiligence]

WSJ reporting that ABT is selling its ophthalmology unit to JNJ:

http://www.wsj.com/articles/j-j-nears-deal-to-buy-abbotts-eye-surgery-equipment-unit-1474043861

ABT acquired this business, then called Advanced Medical Optics, for $2.8B in 2009 (#msg-34762429). AMO was spun off from the original Allergan in 2002.

[DewDiligence]

ABT reports 3Q16 results:

http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyMzY3ODl8Q2hpbGRJRD02NDg3MjM=

ABT narrowed its 2016 non-GAAP EPS guidance to $2.19-2.21 (from the prior range of $2.14-2.24).

I’ll have more to say after the CC.